XTL Biopharmaceuticals Lt... (XTLB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.75
0.00 (0.00%)
At close: Jan 15, 2025, 10:16 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.37M | 938.00K | n/a | n/a | n/a | 5.94M | 907.00K | 454.00K | 3.20M | 3.45M | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17.00 | 741.00K | 380.00K | n/a | n/a | n/a | n/a | 110.00K | 54.00K | 2.80M | 3.30M | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17 | 1.63M | 558.00K | n/a | n/a | n/a | 5.94M | 797.00K | 400.00K | 400.00K | 153.00K | n/a | n/a | n/a |
Operating Income | -765.00K | -880.00K | -1.03M | -948.00K | -842.00K | -793.00K | -1.25M | -2.56M | -3.61M | -2.02M | -2.89M | -2.36M | -1.16M | -1.26M | 2.57M | -9.59M | -25.73M | -16.05M | -14.38M | -16.78M | 14.56M | -17.71M | -15.12M |
Interest Income | 36.00 | 36.00K | 8.00K | 33.00K | 93.00K | 87.00K | 16.00K | n/a | n/a | 10.00K | 10.00K | 43.00K | 45.00K | 2.00K | 3.00K | 317.00K | 668.00K | 1.06M | 503.00K | 352.00K | 352.00K | n/a | n/a |
Pretax Income | -1.78M | -1.35M | 435.00K | -782.00K | -1.35M | 2.99M | -781.00K | -2.54M | -3.62M | -2.12M | -3.71M | -1.74M | -1.21M | -1.26M | 2.56M | -9.28M | -25.14M | -14.90M | -13.94M | -16.42M | -14.21M | -17.11M | n/a |
Net Income | -1.78K | -1.35M | 435.00K | -782.00K | -1.35M | 2.99M | -781.00K | -2.54M | -4.31M | -2.53M | -2.48M | -1.39M | -1.21M | -1.26M | 2.59M | -9.25M | -24.94M | -15.13M | -14.02M | -16.47M | -14.29M | -17.14M | -12.67M |
Selling & General & Admin | 734.00K | 850.00K | 1.00M | 910.00K | 807.00K | 755.00K | 1.19M | 1.26M | 1.41M | 1.72M | 3.67M | 3.55M | 1.00M | 1.22M | 2.43M | 5.14M | 5.58M | 5.58M | 5.46M | 4.13M | 3.10M | 3.64M | 3.00M |
Research & Development | 31.00K | 30.00K | 30.00K | 38.00K | 35.00K | 38.00K | 43.00K | 443.00K | 578.00K | 278.00K | 113.00K | 99.00K | 158.00K | 64.00K | n/a | 10.39M | 20.95M | 10.87M | 7.54M | 12.79M | 11.10M | 13.16M | 11.05M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 765.00K | 880.00K | 1.03M | 948.00K | 842.00K | 793.00K | 1.25M | 1.71M | 2.00M | 2.02M | 3.85M | 3.70M | 1.16M | 1.26M | 2.29M | 15.53M | 26.53M | 16.45M | 13.00M | 16.93M | -14.56M | 17.71M | 15.12M |
Interest Expense | n/a | n/a | n/a | n/a | 29.00K | n/a | n/a | n/a | n/a | n/a | 35.00K | 15.00K | 8.00K | n/a | 2.00K | 3.00K | 4.00K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.69M | 848.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 765.00K | 880.00K | 1.03M | 948.00K | 842.00K | 793.00K | 1.25M | 1.71M | 2.00M | 2.02M | 4.59M | 4.08M | 1.16M | 1.26M | 2.29M | 15.53M | 26.64M | 16.50M | 15.79M | 20.23M | -14.56M | 17.71M | 15.12M |
Income Tax | n/a | 468.00K | -1.47M | -166.00K | -69.00K | -80.00K | -457.00K | 832.00K | 2.31M | 505.00K | 458.00K | -1.19M | 6.00K | n/a | -23.00K | -31.00K | -206.00K | 227.00K | 78.00K | 49.00K | 78.00K | 27.00K | 12.67M |
Shares Outstanding (Basic) | 544.95M | 544.91M | 615.55M | 514.21M | 514.21M | 514.21M | 470.19M | 274.04M | 263.73M | 231.22M | 223.61M | 217.69M | 204.03M | 113.40M | 58.56M | 58.55M | 45.70M | 40.35M | 34.02M | 26.95M | 22.34M | 22.23M | 22.19M |
Shares Outstanding (Diluted) | 544.91M | 544.91M | 615.55M | 514.21M | 514.21M | 514.21M | 470.19M | 274.04M | 263.73M | 231.22M | 223.61M | 217.69M | 204.03M | 113.40M | 58.77M | 58.55M | 45.70M | 40.35M | 337.08M | 274.53M | 22.34M | 22.23M | 22.19M |
EPS (Basic) | n/a | -0.00 | 0.00 | -0.00 | -0.00 | 0.01 | -0.00 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.04 | -0.16 | -0.55 | -0.38 | -0.41 | -0.61 | -0.64 | -0.77 | -0.57 |
EPS (Diluted) | n/a | -0.00 | 0.00 | -0.00 | -0.00 | 0.01 | -0.00 | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | 0.04 | -0.16 | -0.55 | -0.38 | -0.04 | -0.06 | -0.64 | -0.77 | -0.57 |
EBITDA | -764.00K | -879.00K | -1.03M | -947.00K | n/a | -792.00K | -1.25M | -1.71M | -2.00M | -1.97M | -1.10M | -3.80M | -1.06M | -1.21M | 2.58M | -18.40M | -25.63M | -15.80M | -12.36M | -16.46M | 15.36M | -17.71M | -15.12M |
Depreciation & Amortization | 1K | 1K | 1K | 1K | 842.00K | 1K | 1K | 3.00K | 7.00K | 53.00K | 313.00K | 136.00K | 94.00K | 42.00K | 13.00K | 39.00K | 108.00K | 243.00K | 242.00K | 319.00K | 440.00K | n/a | n/a |